Advertisement

Topics

Safety and Efficacy Study of Cilostazol to Treat Vasospastic Angina

2014-09-24 15:14:26 | BioPortfolio

Published on BioPortfolio: 2014-09-24T15:14:26-0400

Clinical Trials [203 Associated Clinical Trials listed on BioPortfolio]

Statin Therapy In Patients With Vasospastic Angina

The purpose of this study is to evaluate whether statin is effective in the treatment of vasospastic angina.

Efficacy Study of Atorvastatin to Treat Variant Angina

The objective of this study is to evaluate effect of statin treatment for vasospastic angina.

Effects of Cilostazol on Plasma Adipocytokine and Arterial Stiffness

Cilostazol is an antiplatelet agent used to reduce the symptoms of intermittent claudication. Cilostazol inhibits phosphodiesterase III (PDE III), which causes it to be a vasodilator and i...

Noninvasive Cardiac Imaging in Vasospastic Angina Korean Registry (NAVIGATOR)

With regard to the characteristics of spasm segment, had been clearly described by other invasive imaging methods including intravascular ultrasound and optical coherence tomography. Howev...

Cilostazol After Lower Extremity Arterial Revascularization Trial

Ten patients will be recruited to CLEAR. Five will be randomized to the treatment arm (Cilostazol) and five will be randomized to the control group. Patients randomized to the treatment ar...

PubMed Articles [124 Associated PubMed Articles listed on BioPortfolio]

A case report of Brugada-like ST-segment elevation probably due to coronary vasospasm.

Vasospastic angina is caused by sudden occlusive vasoconstriction of a segment of an epicardial artery, with transient ST-segment elevation on electrocardiography. Brugada Syndrome is an inherited arr...

The Rho(ad)-kinase for individualized treatment of vasospastic angina.

Ranolazine for Symptomatic Management of Microvascular Angina.

Ranolazine is approved in the United States and Europe for chronic stable angina. Microvascular angina (MVA) is defined as angina with no obstructive coronary artery disease.

MicroRNA-132 targeting PTEN contributes to cilostazol-promoted vascular smooth muscle cell differentiation.

Cilostazol, beyond its antiplatelet effect, is also capable of promoting vascular smooth muscle cell (VSMC) differentiation. The aim of this study was to explore the potential role of PTEN, known to a...

Association Between Alcohol Use and Angina Symptoms Among Outpatients From the Veterans Health Administration.

Alcohol use is associated with angina incidence, but associations between alcohol use and experience of angina among patients with coronary artery disease (CAD) have not been described.

Medical and Biotech [MESH] Definitions

ANGINA PECTORIS or angina-like chest pain with a normal coronary arteriogram and positive EXERCISE TEST. The cause of the syndrome is unknown. While its recognition is of clinical importance, its prognosis is excellent. (Braunwald, Heart Disease, 4th ed, p1346; Jablonski Dictionary of Syndromes & Eponymic Diseases, 2d ed). It is different from METABOLIC SYNDROME X, a syndrome characterized by INSULIN RESISTANCE and HYPERINSULINEMIA, that has increased risk for cardiovascular disease.

A vasodilator used in angina of effort or ischemic heart disease.

Precordial pain at rest, which may precede a MYOCARDIAL INFARCTION.

2-(2,2-Dicyclohexylethyl)piperidine. Coronary vasodilator used especially for angina of effort. It may cause neuropathy and hepatitis.

A beta-adrenergic antagonist used in the treatment of hypertension, angina pectoris, arrhythmias, and anxiety.

More From BioPortfolio on "Safety and Efficacy Study of Cilostazol to Treat Vasospastic Angina"

Advertisement
Quick Search
Advertisement
Advertisement

 

Searches Linking to this Trial